Tonya M. Bliss*, Robert H. Andres, Gary K. Steinberg
Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA, USA
The authors have noted that data on two additional clinical trials involving stem cell therapy for stroke has become available since the article was published, and would like to have an addendum to the appropriate table. The addendum to the table appears below.
[Insert “Addendum to YNBDI 1994.doc” here]
DOI of original article: 10.1016/j.nbd.2009.10.003
*Corresponding author: +1 650 498 4134.
E-mail address: tbliss1@stanford.edu (T.M. Bliss)
Addendum to Table 2. Current clinical cell transplantation trials for stroke.
Two additional trials have been identified since publication of the manuscript
| Clinical Identifier & Clinical phase | Cell Type | Estimated enrollment | Time of delivery* | Route of delivery | Country |
|---|---|---|---|---|---|
|
NCT00761982a Phase I/II |
autologous bone marrow | 20 | 5d–9d | intra-arterial | Spain |
| CTR1/2008/091/000046b Phase II |
autologous bone marrow | 120 | 7d–30d | intravenous | India |
Clinical identifier from
Clinicaltrials.gov,
time of delivery after stroke on-set
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.